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QTc Dispersion Predicts Cardiac Mortality in the Elderly
The Rotterdam Study
M.C. de Bruyne, MD; A.W. Hoes, MD, PhD; J.A. Kors, PhD; A. Hofman, MD, PhD;
J.H. van Bemmel, PhD; D.E. Grobbee, MD, PhD
Background—Increased QTc dispersion has been associated with an increased risk for ventricular arrhythmias and cardiac
death in selected patient populations. We examined the association between computerized QTc-dispersion measurements
and mortality in a prospective analysis of the population-based Rotterdam Study among men and women aged $55 years.
Methods and Results—QTc dispersion was computed with the use of the Modular ECG Analysis System as the difference
between the maximum and minimum QTc intervals in 12 and 8 leads (ie, the 6 precordial leads, the shortest extremity
lead, and the median of the 5 other extremity leads). After exclusion of those without a digitally stored ECG, the
population consisted of 2358 men and 3454 women. During the 3 to 6.5 years (mean, 4 years) of follow-up, 568 subjects
(9.8%) died. The degree of QTc dispersion was categorized into tertiles. Data were analyzed using the Cox proportional
hazards model, with adjustment for age. For QTc dispersion in 8 leads, those in the highest tertile relative to the lowest
tertile had a twofold risk for cardiac death (hazard ratio, 2.5; 95% confidence interval [CI], 1.6 to 4.0) and sudden cardiac
death (hazard ratio, 1.9; 95% CI, 1.0 to 3.7) and a 40% increased risk for total mortality (hazard ratio, 1.4; 95% CI, 1.2
to 1.8). Additional adjustment for potential confounders, including history of myocardial infarction, hypertension, and
overall QTc, did not materially change the risk estimates. Hazard ratios for QTc dispersion in 12 leads were comparable
to those found for QTc dispersion in 8 leads.
Conclusions—QTc dispersion is an important predictor of cardiac mortality in older men and women. (Circulation.
1998;97:467-472.)
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Recent clinical studies have suggested that the interleadvariability of the QT interval in the standard ECG, defined
as QT dispersion, reflects regional differences in ventricular
repolarization.1,2 Increased dispersion of recovery time is be-
lieved to increase the risk for serious ventricular arrhythmias.3–6
It is hypothesized that an important entity underlying QT
dispersion is patchy myocardial fibrosis, resulting from myo-
cardial ischemia, ventricular dilatation, and neurohormonal
activation.3,7 This is supported by findings of increased QT
dispersion in patients with acquired long-QT interval,1,8
MI,2,9,10 hypertrophic cardiomyopathy,11,12 and hypertension
and LVH13 and in diabetic patients with autonomic neuropa-
thy.14 Moreover, QT dispersion has been associated with
increased risk for ventricular arrhythmias and sudden death in
patients with chronic heart failure,15 mitral valve prolapse,16
MI,17 and familial long-QT syndrome1 and with an increased
risk for cardiac mortality in patients with peripheral arterial
disease7 and MI.18
In these previous studies, QT dispersion was measured
retrospectively and manually in a limited number of cases and
controls by one or more observers with the use of a digitizing
tablet. Evidence from large, prospective studies on the prog-
nostic implications of QT dispersion is lacking. The use of a
computer program to measure QT dispersion facilitates large
studies and excludes intraobserver and interobserver variability.
We assumed that the risk associated with increased QT
dispersion applies not only to patient populations but also to
the population at large; therefore, we examined whether
increased QT dispersion, established by computer analysis, was
associated with a higher risk for total mortality, cardiac death,
sudden cardiac death, and nonfatal cardiac disease in a large
nonhospitalized population of older adults.
Methods
Study Population and Baseline Data Collection
This study is part of the Rotterdam Study, a population-based cohort
study aimed at assessing the occurrence and risk factors for chronic diseases
in the elderly. Objectives and methods of the Rotterdam Study have been
described in detail.19 Briefly, in the Rotterdam Study, all men and women
aged $55 years who live in the Rotterdam district Ommoord were
invited to participate (response rate, 78%). Of 7129 participants, the
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baseline data, collected from 1990 to 1993, included an ECG and
information on history of cardiovascular disease, established cardiovascular
risk factors, and use of medications.
A digitally stored ECG was available for 6160 participants (86%).
An ECG was missing for 14% of the participants, mainly due to
temporary technical problems of the ECG recorder. Blood pressure
was calculated as the average of two consecutive measurements with a
random zero mercury manometer. Body mass index was calculated as
weight/length2 in kg/m.2 Hypertension was defined as systolic blood
pressure of .160 mm Hg or diastolic blood pressure of .95 mm Hg
or the use of antihypertensive medication for the indication of
hypertension. Diabetes mellitus was defined as a nonfasting blood
glucose level of .11.1 mmol/L or the use of antidiabetic medication.
History of MI was defined as self-reported MI with hospital admission,
or MI on the ECG. Presence of angina pectoris was established
through use of the Rose Questionnaire.20
After exclusion of 345 subjects without follow-up data, mainly
because they moved to unknown addresses, and 3 subjects with ECGs
of poor technical quality that could not be interpreted by the
computer program, the study population consisted of 2358 men and
3454 women.
Follow-up Procedures
The follow-up period, which started at the baseline examination and
in the present analysis lasted until April 1996, was 3 to 6.5 years (mean,
4 years). With respect to the vital status of participants, information
was obtained at regular intervals from the municipal health service in
Rotterdam. Information on fatal and nonfatal end points was obtained
from the GPs working in the study district of Ommoord. These GPs,
covering '85% of the cohort, have their practices computerized and
report possible fatal and nonfatal events of participants on computer
file to the Rotterdam Study data center on a regular basis. All possible
events reported by the GP were verified by research physicians from
the Rotterdam Study through patient records of the participating GPs
and medical specialists. In April 1996, the medical records of partici-
pants with GPs from outside the Ommoord area, representing '15%
of the cohort, were checked by research physicians, and for all possible
events, additional information for coding was collected.
The cause and circumstances of death were established soon after
the report of death by the municipal health service or the GP through
the use of a questionnaire from the GP and through scrutiny of
information from hospital discharge records in the case of admittance
or referral.
Overall, complete follow-up information was available for 94% of
the population of the Rotterdam Study. Participants for whom no
follow-up information was available were similar to those included in
the present study; they were an average of 3.5 years older (mean age,
73.9 years) and had a lower prevalence of hypertension (25% versus
30%) and diabetes (10% versus 14%). No other differences in baseline
characteristics were found.
Classification of fatal and nonfatal events was based on the Interna-
tional Statistical Classification of Diseases and Related Health Problems, 10th
revision.21 We defined cardiac mortality as death from MI (ICD-10: I21
to I24), chronic ischemic heart disease (ICD-10: I25), pulmonary
embolism or other pulmonary heart disease (ICD-10: I26 to I28),
cardiomyopathy (ICD-10: I42 to I43), cardiac arrest (ICD-10: I46),
arrhythmias (ICD-10: I47 to I49), heart failure (ICD-10: I50), or
sudden cardiac death. Sudden cardiac death was defined as death
occurring instantaneously or within 1 hour after the onset of symp-
toms or unwitnessed death in which a cardiac cause could not be
excluded.22,23 Nonfatal cardiac events were defined as MI (ICD-10:
I21 to I24), chronic ischemic heart disease (ICD-10: I25), coronary
artery bypass graft surgery (no ICD-10 code), or percutaneous
transluminal coronary angioplasty (no ICD-10 code).
All events were classified independently by two research physicians.
If there was disagreement, a consensus was reached in a separate
session. Finally, all events were verified by a medical expert in the field
of cardiovascular disease. In case of discrepancies, the judgment
reached by this expert was considered definite.
ECG Interpretation and Measurements
A 12-lead resting ECG was recorded with an ESAOTE-ACTA
cardiograph with a sampling frequency of 500 Hz and stored digitally.
All ECGs were processed with the use of MEANS to obtain ECG
measurements and diagnostic interpretations. The MEANS program
has been extensively evaluated by the developers and others.24–26 To
adjust QT for heart rate, we calculated QTc according to Bazett’s
formula: QTc5QT/√RR, where RR is the RR interval in seconds.27
Normally, the MEANS program determines an overall end of T
waves for all 12 leads together using a representative beat, which
results from selective averaging of dominant beats, and thus QTc
dispersion is not disclosed. The program was therefore adjusted to
determine the end of the T wave per lead. Taking the location of
the overall end of the T wave as a starting point, the program
searches forward and backward to establish the lead-specific end of
the T wave. If the T wave amplitude is ,50 mV, the T wave is
considered to be flat and the lead is excluded from further analysis.
QTc dispersion is determined as the difference between the
maximum and minimum QTc in all considered leads. Analogously,
QT dispersion is determined as the difference between the maxi-
mum and minimum QT interval, without correction for heart rate,
in all considered leads.
QTc dispersion measured by the MEANS program was validated
against the results of two human observers on a set of 100 ECGs
(unpublished data, 1997). Both observers independently marked the
end of the T wave in each lead with the cursor on a high-resolution
computer screen. We found a mean QTc dispersion difference
between MEANS and pooled data from both observers of 5.1 ms (SD,
29.3 ms). These results are comparable with the interobserver vari-
ability between the two human observers (mean, 6.7 ms; SD, 28.4
ms). Therefore, we concluded that the performance of the program
was comparable to that of human observers.
LVH was determined using voltage as well as repolarization criteria.
A negative T wave was defined as $1.00-mm negative deflection of
the T wave in lead II, aVF, or the precordial leads.
Lead Selection for QTc Dispersion
Traditionally, QTc dispersion is defined as the difference between the
maximum and minimum QTc interval in 12 leads. However, in the
standard 12-lead ECG, only 2 of the 6 extremity leads are actually
recorded. The other 4 leads are derived mathematically from these 2
leads.
It can be shown that if there is a shortest T wave in one of the
extremity leads, the other 5 extremity leads must have the same end of
T (see “Appendix”). As a consequence, true QTc dispersion cannot
exist among these leads, and QTc dispersion measured in these leads
can only be the result of measurement inaccuracy.
Therefore, we defined QTc dispersion as the difference between
the maximum and the minimum QTc interval in 8 leads (ie, the 6
precordial leads, the shortest extremity lead and the median of the 5
other extremity leads). In addition, we computed QTc dispersion in
12 leads. ECGs in which QTc dispersion could be measured in fewer
than 9 of the 12 leads were excluded (n516 of the 5812 subjects in the
present study).
Data Analysis
Differences in baseline characteristics between those with and without
follow-up data were examined with one-way ANCOVA, with
adjustment for age and sex when appropriate.
The degree of QTc dispersion in both 8 and 12 leads was
categorized in tertiles, with intertertile values of 39 and 60 ms (in 8
Selected Abbreviations and Acronyms
CI 5 confidence interval
GP 5 general practitioner
LVH 5 left ventricular hypertrophy
MEANS 5 modular ECG analysis system
MI 5 myocardial infarction
468 QTc Dispersion Predicts Cardiac Mortality
leads) and 47 and 66 ms (in 12 leads) respectively. In addition, QT
dispersion in 8 and 12 leads was categorized in tertiles. All analyses
were performed for both 8- and 12-lead measures of dispersion.
To evaluate the association between QTc dispersion and potentially
confounding factors, differences in the distribution of selected baseline
characteristics between subjects in tertiles of QTc dispersion were
examined with one-way ANCOVA, with adjustment for age and sex
when appropriate.
The Cox proportional hazards model was used to examine the risk
for cardiac and total mortality and nonfatal cardiac events in relation to
tertile of baseline QTc and QT dispersion, with adjustment for two
sets of confounders: age and sex (the latter only when non–sex-specific
risks were estimated), and all possible confounders, excluding other
ECG abnormalities, resulting from the ANCOVA (P,.05). The
lowest tertile of QTc dispersion or QT dispersion was taken as the
reference category. To minimize the effect of missing data in the
multivariate analysis, missing values of categorical variables were
replaced by dummies. Missing values of continuous variables were
replaced by the average value, and a dummy variable (to indicate that
the participant’s individual value was missing) was added to the
model.28
To compare predictive value of QTc dispersion with that of other
commonly used cardiovascular risk indicators, age- and sex-adjusted
hazard ratios for cardiac mortality of important cardiovascular risk
indicators were computed.
Influence of age and history of MI on the risk for cardiac death
associated with increased QTc dispersion was examined through
subgroup analyses for these possible effect modifiers.
Results
Baseline characteristics of participants in different tertiles of
QTc dispersion are presented in Table 1. Statistically signifi-
cant differences existed among the three comparison groups
with regard to age, systolic and diastolic blood pressure,
hypertension, diabetes mellitus, history of MI, overall QTc
interval, presence of negative T waves, and LVH on the basis
of ECG.
The distribution of QTc dispersion, measured in both 8 and
12 leads, in cases of cardiac death during the follow-up period
was shifted to the right compared with survivors (Fig 1). In
addition, QTc dispersion in 12 leads was shifted to the right
compared with the distribution in 8 leads, reflecting larger
dispersion in 12 than in 8 leads.
During the 3 to 6.5 years (mean, 4 years) of follow-up, 568
subjects (9.8%) died: 166 (2.9%) died of a cardiac cause and 73
(1.3%) died suddenly. In 193 of the subjects (3.3%), at least one
nonfatal cardiac event occurred. Cardiac mortality according
to tertile of QTc dispersion for men and women is presented
in Fig 2a and 2b. It appears that in men, increased risk for
cardiac mortality starts at a lower level of QTc dispersion than
in women.
Participants in the highest tertile relative to the lowest tertile
of QTc dispersion in 8 leads had a more than twofold age- and
sex-adjusted risk for cardiac death (hazard ratio, 2.5; 95% CI,
Figure 1. Distribution of QTc dispersion measured in 8 and 12
leads in those who die from a cardiac cause and in survivors
among 5812 men and women aged $55 years.
TABLE 1. Baseline Characteristics of Study Participants According to Tertiles of QTc Dispersion
Characteristic
All
(n55812)
T1
<39 ms
T2
39 to 60 ms
T3
>60 ms P
Age, y 69.3 (9.0) 68.4 69.1 70.0 ,.01
Sex, % women 59.4 58.4 59.1 60.5 NS
Systolic blood pressure, mm Hg 139.4 (22.4) 138.0 138.5 141.3 ,.01
Diastolic blood pressure, mm Hg 73.5 (11.6) 73.1 73.2 74.0 ,.05
Body mass index, kg/m2 26.3 (3.7) 26.5 26.4 26.2 NS
Cholesterol, mmol/L 6.6 (1.2) 6.6 6.6 6.6 NS
Current smoking, % 23.1 22.0 23.0 23.9 NS
Use of cardiovascular medication, % 36.0 34.4 36.1 37.2 NS
Hypertension, % 29.6 27.4 28.4 32.2 ,.01
Diabetes, % 12.7 11.2 11.9 14.4 ,.01
Angina pectoris, % 6.8 7.1 7.5 6.0 NS
Myocardial infarction, % 13.0 11.5 12.5 14.5 ,.05
Overall QTc, ms 431 (29) 429 430 434 ,.01
Negative T wave, % 7.8 5.6 7.6 9.4 ,.01
LVH on ECG, % 4.9 3.4 4.8 6.1 ,.01
T1 indicated lowest tertile of QTc dispersion; T2, middle tertile of QTc dispersion; T3, highest tertile of QTc dispersion; and LVH, left
ventricular hypertrophy.
Values are mean (SD) or percentages. P values are presented for equality of tertile-specific values (T1 through T3) for tertiles of QTc
dispersion in eight leads, adjusted for age and sex using one-way ANCOVA.
de Bruyne et al 469
1.6 to 4.0) and sudden cardiac death (hazard ratio, 1.9; 95% CI,
1.0 to 3.7) and an increased risk for total mortality (hazard
ratio, 1.4; 95% CI, 1.2 to 1.8) and nonfatal cardiac events
(hazard ratio, 1.3; 95% CI, 0.9 to 1.8), although the latter result
was not statistically significant (Table 2). Additional adjustment
for hypertension, diabetes, and history of MI did not materially
change hazard ratio estimates for cardiac and all-cause mortal-
ity, although the 95% CI of the adjusted hazard ratios for
sudden death events included one. Inclusion of other ECG
abnormalities, notably LVH, negative T waves, and maximum
QTc interval, in this model did not influence the results.
QTc dispersion in both 8 and 12 leads ranks among the
strongest predictors for cardiac mortality (Fig 3). The highest
age- and sex-adjusted hazard ratios for cardiac mortality were
found for LVH (hazard ratio, 2.6; 95% CI, 1.7 to 4.0) and QTc
dispersion in 8 leads .60 ms (hazard ratio, 2.5; 95% CI, 1.6 to
4.0), whereas in the multivariate model, QTc dispersion in 8
leads .60 ms was the strongest predictor for cardiac mortality,
followed by history of MI (hazard ratio, 2.0; 95% CI, 1.5 to
2.5). The corresponding multivariate hazard ratio for cardiac
death for QTc .440 ms was identical to the age- and
sex-adjusted hazard ratio, notably 2.3 (95% CI, 1.0 to 2.1).
Subgroup analysis showed that the risk for cardiac death
associated with increased QTc dispersion for participants in the
highest relative to the lowest tertile of QTc dispersion was not
Figure 2. a, Cardiac mortality (percentage) by tertile of QTc dis-
persion in 8 leads in men. b, Cardiac mortality (percentage) by
tertile of QTc dispersion in 8 leads in women.
Figure 3. Age- and sex-adjusted hazard ratios QTc dispersion
in 8 and 12 leads and other commonly used cardiovascular risk
indicators and ECG abnormalities. QTcD8 indicates QTc disper-
sion in 8 leads; QTcD12, QTc dispersion in 12 leads.
TABLE 2. Hazards Ratios in Subjects in the Middle and Highest Tertiles Relative to the Lowest
Tertile of QTc Dispersion Measured in Eight Leads and Adjusted for Age and Sex (Model A) and for
All Possible Confounders (Model B)
End Point Subgroup
Model A Model B
T2 39 to 60 ms T3>60 ms T2 39 to 60 ms T3 >60 ms
Total mortality All 1.3 (1.1-1.7) 1.4 (1.2-1.8) 1.3 (1.1-1.7) 1.4 (1.1-1.8)
Men 1.5 (1.0-2.0) 1.4 (1.0-1.9) 1.5 (1.1-2.1) 1.3 (1.0-1.8)
Women 1.2 (0.9-1.7) 1.5 (1.1-2.0) 1.2 (0.9-1.7) 1.5 (1.1-2.0)
Cardiac mortality All 2.1 (1.3-3.4) 2.5 (1.6-4.0) 2.0 (1.3-3.3) 2.4 (1.5-3.8)
Men 3.3 (1.6-6.9) 2.5 (1.2-5.2) 3.3 (1.6-6.9) 2.3 (1.1-4.8)
Women 1.2 (0.6-2.5) 2.5 (1.4-4.6) 1.2 (0.6-2.4) 2.5 (1.3-4.5)
Sudden cardiac death All 1.8 (0.9-3.5) 1.9 (1.0-3.7) 1.8 (0.9-3.5) 1.8 (0.9-3.5)
Men 3.0 (1.1-8.1) 2.4 (0.9-6.6) 3.0 (1.1-8.1) 2.3 (0.8-6.1)
Women 0.9 (0.3-2.5) 1.6 (0.6-3.8) 0.9 (0.3-2.5) 1.5 (0.6-3.5)
Nonfatal cardiac events All 0.9 (0.6-1.3) 1.3 (0.9-1.8) 0.9 (0.6-1.3) 1.3 (0.9-1.8)
Men 0.8 (0.5-1.3) 1.2 (0.8-1.8) 0.8 (0.5-1.3) 1.1 (0.7-1.7)
Women 1.0 (0.5-2.0) 1.6 (0.9-3.0) 1.0 (0.5-1.9) 1.6 (0.9-2.9)
Model A indicates adjusted for age; model B, adjusted for age, and presence of hypertension, diabetes mellitus, and history of
myocardial infarction; T2, middle tertile of QTc dispersion; and T3, highest tertile of QTc dispersion.
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modified by age but was more pronounced in those without a
history of MI (hazard ratio, 3.5; 95% CI, 1.8 to 6.9) than in those
with a history of MI (hazard ratio, 1.8; 95% CI, 0.8 to 3.9).
The risks associated with QTc dispersion based on 12 leads
was very similar to the risk associated with QTc dispersion in
8 leads (Table 3). Hazard ratios tended to be higher in QTc
dispersion in 8 leads compared with QTc dispersion in 12
leads, but 95% CIs hardly differed.
The risk estimates for the various end points associated with
QT dispersion, without correction of the QT interval for heart
rate, in 8 and 12 leads were similar but had wider 95% CIs
compared with the risk estimates for QTc dispersion in 8 and
12 leads.
Discussion
The results of this study show that increased QTc dispersion is
a strong and independent risk factor for cardiac mortality in
older men and women.
Previous studies were performed in patient populations. Their
findings that QT dispersion is larger in those with MI,2,9,10
hypertension, LVH,13 and diabetes mellitus14 are confirmed by
ours. Increased risk for cardiac mortality associated with QTc
dispersion has been reported in patients with peripheral artery
disease7 and MI.18 Our findings provide support for an association
of increased QTc dispersion and cardiac death in those with and
without coronary heart disease. However, differences in mean
values of QTc dispersion in those who die from a cardiac cause
compared with survivors were much more pronounced in these
earlier studies: 25 to 30 ms versus 4 to 6 ms in the Rotterdam
Study. This may be explained by differences in severity of the
underlying disease in the population at large compared with
patient populations. In addition, differences in measurement
techniques may play a role.
Our findings are in accordance with the hypothesis that
QTc dispersion is due to patchy myocardial fibrosis resulting
from MI, ventricular dilatation, and neurohormonal activation
because we found a positive association of QTc dispersion with
many cardiovascular risk indicators.
Regardless of the technique used, QTc dispersion is difficult
to measure. The end of repolarization, assessed as the end of
the T wave, is a gradual process and therefore hard to define.
The definition of the end of the T wave is further complicated
by low-amplitude T waves and the presence of U waves.
Differences in measurement techniques, by hand or computer,
are known to be the source of large variations in absolute
values of QT intervals.26 Prior studies have shown that mea-
surement of QTc dispersion is characterized by from large
measurement error and has a poor reproducibility in both
manual and computerized measurements29–33; therefore, re-
ported risk estimates are likely to be substantially diluted.
QTc dispersion in 12 leads was larger than QTc dispersion
in 8 leads. Because this difference probably is due mainly to
measurement error, it seems preferable to measure QTc
dispersion in 8 leads, although any difference between QTc
dispersion in 8 and 12 leads has little effect on the risk
associated with QTc dispersion.
We conclude that QTc dispersion is a strong and indepen-
dent predictor of cardiac mortality in older men and women.
Further studies are warranted to study the mechanism under-
lying QTc dispersion and to search for the most accurate
measure of this mechanism.
Appendix: Relationship Between
Extremity Leads
In the standard 12-lead ECG, only 2 of the 6 extremity leads are
actually recorded (eg, leads I and II); the other 4 leads are derived from
mathematical relationships imposed by the lead system. Thus, for the
amplitudes in the extremity leads at any time, it holds that III5II2I,
aVR52(I1II)/2, aVL5(I2III)/2, and aVF5(II1III)/2. If all T
waves end at the same moment, of course QT dispersion (QTD)50.
Suppose the T wave in 1 lead, say I, is shorter than that in the other
leads, ending at some time instant t1. Then, with lead I equal to 0,
III5II for t.t1. This means that II and III must end at the same time.
Let us assume this moment to be t2. In the time interval t12t2, lead
I50, and using the above basic relationships, aVR52II/2,
TABLE 3. Hazards Ratios in Subjects in the Middle and Highest Tertile Relative to the Lowest
Tertile of QTc Dispersion Measured in 12 Leads and Adjusted for Age and Sex (Model A) and for All
Possible Confounders (Model B)
End Point Subgroup
Model A Model B
T2 47 to 66 ms T3 >66 ms T2 47 to 66 ms T3 >66 ms
Total mortality All 1.3 (1.0-1.6) 1.3 (1.1-1.6) 1.3 (1.0-1.6) 1.3 (1.0-1.6)
Men 1.5 (1.1-2.1) 1.2 (0.8-1.6) 1.6 (1.2-2.2) 1.1 (0.8-1.6)
Women 1.1 (0.8-1.5) 1.4 (1.1-1.9) 1.1 (0.8-1.5) 1.4 (1.1-1.9)
Cardiac mortality All 1.9 (1.2-3.0) 2.2 (1.4-3.4) 1.9 (1.2-3.0) 2.1 (1.4-3.3)
Men 2.9 (1.5-5.6) 1.9 (1.0-3.8) 3.1 (1.6-5.9) 1.8 (0.9-3.5)
Women 1.2 (0.6-2.3) 2.4 (1.4-4.3) 1.1 (0.6-2.2) 2.4 (1.4-4.3)
Sudden cardiac death All 1.8 (0.9-3.4) 1.7 (0.9-3.1) 1.8 (0.9-3.5) 1.7 (0.9-3.1)
Men 2.1 (0.8-5.8) 1.9 (0.7-5.5) 4.2 (1.6-11.3) 2.2 (0.8-6.1)
Women 1.8 (0.6-5.8) 2.6 (1.0-6.6) 0.6 (0.2-1.8) 1.4 (0.6-3.3)
Nonfatal cardiac events All 0.9 (0.7-1.4) 1.3 (0.9-1.8) 1.0 (0.7-1.5) 1.4 (1.0-1.9)
Men 0.9 (0.5-1.4) 1.3 (0.9-2.0) 1.0 (0.6-1.6) 1.3 (0.9-2.0)
Women 1.2 (0.6-2.4) 1.2 (0.6-2.2) 0.9 (0.5-1.8) 1.5 (0.8-2.7)
See Table 2 for abbreviations.
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aVL52III/2, and aVF5II5III. Thus, the T waves in all augmented
leads end when the T waves in the leads II and III end (ie, at t2). The
same argument can be applied to any extremity lead other than I. It is
always true that if there is a shortest T wave in 1 of the extremity leads
ending at some time t1, the T waves in the other 5 extremity leads
must all end at the same time instant t2.t1. As a consequence, QTD
cannot exist among these leads, and any measured QTD can only be
the result of measuring inaccuracy. The only possible true dispersion
is between these 5 leads and the single short lead, QTD5t22t1.
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